Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study
Acta Ophthalmologica Jan 31, 2018
Kianersi F, et al. - As a part of this study, researchers gauged the impact of single intravitreal diclofenac (IVD) injection on the short-term outcome of refractory uveitis-associated cystoid macular oedema (CME). Findings reported the possibility of intravitreal diclofenac (IVD) serving as a promising treatment for refractory uveitis-associated CME.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
